Literature DB >> 5789672

Lymphocyte to macrophage transformation in the peritoneal cavity preceding the mobilization of peritoneal macrophages to inflamed areas.

B Vernon-Roberts.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 5789672     DOI： 10.1038/2221286a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  Professor Barrie Vernon-Roberts, AO, MD, BSc, PhD, FRCPath, FRCPA, FAOrthA (Hon), FRS.SA.

Authors:  K D Rainsford; D R Haynes
Journal:  Inflammopharmacology       Date:  2013-07-04       Impact factor: 4.473

2.  T and B cells in the blood and synovial fluid of rheumatoid patients.

Authors:  B Vernon-Roberts; H L Currey; J Perrin
Journal:  Ann Rheum Dis       Date:  1974-09       Impact factor: 19.103

3.  Normal peritoneal lymphocytes: A population with increased capacity for endocytosis.

Authors:  P J Catanzaro; R C Graham
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

4.  A simple procedure for identification of macrophages in peritoneal exudates.

Authors:  F De Halleux; H S Taper; C Deckers
Journal:  Br J Exp Pathol       Date:  1973-08

5.  [Immunologic defense against infections].

Authors:  H G Schwick; K Heide
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1970

6.  Lymphatic efflux of intracerebrally injected cells.

Authors:  M Oehmichen; H Grüninger; H Wiethölter; M Gencic
Journal:  Acta Neuropathol       Date:  1979-01-12       Impact factor: 17.088

Review 7.  Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin®) and metallic silver.

Authors:  Michael Whitehouse; Desley Butters; Barrie Vernon-Roberts
Journal:  Inflammopharmacology       Date:  2013-05-19       Impact factor: 4.473

8.  Amelioration of severe TNBS induced colitis by novel AP-1 and NF- κ B inhibitors in rats.

Authors:  Magdy El-Salhy; Kazuo Umezawa; Odd Helge Gilja; Jan G Hatlebakk; Doris Gundersen; Trygve Hausken
Journal:  ScientificWorldJournal       Date:  2014-01-30

Review 9.  Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.

Authors:  Yinzhi Lin; Tamami Ukaji; Naoki Koide; Kazuo Umezawa
Journal:  Int J Mol Sci       Date:  2018-03-03       Impact factor: 5.923

Review 10.  Anticancer Activity of Novel NF-kappa B Inhibitor DHMEQ by Intraperitoneal Administration.

Authors:  Kazuo Umezawa; Andrzej Breborowicz; Shamil Gantsev
Journal:  Oncol Res       Date:  2020-06-23       Impact factor: 5.574
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.